

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 5.67677176 |
| 2 | muscle filament sliding (GO:0030049) | 5.67677176 |
| 3 | modulation by virus of host process (GO:0019054) | 4.90731959 |
| 4 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.81698930 |
| 5 | modulation by symbiont of host cellular process (GO:0044068) | 4.57098510 |
| 6 | actin-mediated cell contraction (GO:0070252) | 4.45696981 |
| 7 | skeletal muscle contraction (GO:0003009) | 4.35481117 |
| 8 | creatine metabolic process (GO:0006600) | 4.15950292 |
| 9 | kynurenine metabolic process (GO:0070189) | 4.01517581 |
| 10 | NADH metabolic process (GO:0006734) | 3.92919983 |
| 11 | cardiac muscle contraction (GO:0060048) | 3.91936703 |
| 12 | response to muscle activity (GO:0014850) | 3.91777862 |
| 13 | striated muscle contraction (GO:0006941) | 3.88843765 |
| 14 | myofibril assembly (GO:0030239) | 3.84176958 |
| 15 | tryptophan catabolic process (GO:0006569) | 3.78997086 |
| 16 | indole-containing compound catabolic process (GO:0042436) | 3.78997086 |
| 17 | indolalkylamine catabolic process (GO:0046218) | 3.78997086 |
| 18 | L-phenylalanine catabolic process (GO:0006559) | 3.75086187 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.75086187 |
| 20 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.74515803 |
| 21 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.73820012 |
| 22 | L-phenylalanine metabolic process (GO:0006558) | 3.73820012 |
| 23 | aromatic amino acid family catabolic process (GO:0009074) | 3.71256380 |
| 24 | regulation of skeletal muscle contraction (GO:0014819) | 3.65475887 |
| 25 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.63516392 |
| 26 | sarcomere organization (GO:0045214) | 3.56891156 |
| 27 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.48646329 |
| 28 | actin filament-based movement (GO:0030048) | 3.43891712 |
| 29 | tryptophan metabolic process (GO:0006568) | 3.40772980 |
| 30 | cardiac myofibril assembly (GO:0055003) | 3.35130295 |
| 31 | bile acid biosynthetic process (GO:0006699) | 3.30131836 |
| 32 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.23347578 |
| 33 | modulation by virus of host morphology or physiology (GO:0019048) | 3.22210613 |
| 34 | skeletal muscle fiber development (GO:0048741) | 3.19955289 |
| 35 | glutamate metabolic process (GO:0006536) | 3.16316683 |
| 36 | 2-oxoglutarate metabolic process (GO:0006103) | 3.13977683 |
| 37 | coenzyme catabolic process (GO:0009109) | 3.12242658 |
| 38 | muscle contraction (GO:0006936) | 3.09163561 |
| 39 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.06424113 |
| 40 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.05902307 |
| 41 | lysine catabolic process (GO:0006554) | 3.05099571 |
| 42 | lysine metabolic process (GO:0006553) | 3.05099571 |
| 43 | ribosomal small subunit biogenesis (GO:0042274) | 3.04185355 |
| 44 | negative regulation of necroptotic process (GO:0060546) | 3.02074862 |
| 45 | regulation of glucocorticoid secretion (GO:2000849) | 3.01371982 |
| 46 | cellular modified amino acid catabolic process (GO:0042219) | 2.99644120 |
| 47 | negative regulation of necrotic cell death (GO:0060547) | 2.99163347 |
| 48 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.96734442 |
| 49 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.95369834 |
| 50 | cellular ketone body metabolic process (GO:0046950) | 2.94361811 |
| 51 | regulation of early endosome to late endosome transport (GO:2000641) | 2.93243071 |
| 52 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.92850154 |
| 53 | regulation of relaxation of muscle (GO:1901077) | 2.91533003 |
| 54 | high-density lipoprotein particle remodeling (GO:0034375) | 2.88315824 |
| 55 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.85832601 |
| 56 | glyoxylate metabolic process (GO:0046487) | 2.84729925 |
| 57 | oxaloacetate metabolic process (GO:0006107) | 2.82851529 |
| 58 | regulation of corticosteroid hormone secretion (GO:2000846) | 2.81921097 |
| 59 | short-chain fatty acid metabolic process (GO:0046459) | 2.81318510 |
| 60 | urea metabolic process (GO:0019627) | 2.81115050 |
| 61 | urea cycle (GO:0000050) | 2.81115050 |
| 62 | cardiac muscle hypertrophy (GO:0003300) | 2.79362243 |
| 63 | alpha-linolenic acid metabolic process (GO:0036109) | 2.79228523 |
| 64 | sulfur amino acid catabolic process (GO:0000098) | 2.78980869 |
| 65 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.78414025 |
| 66 | positive regulation of receptor recycling (GO:0001921) | 2.78131573 |
| 67 | positive regulation of myotube differentiation (GO:0010831) | 2.77892569 |
| 68 | cysteine metabolic process (GO:0006534) | 2.76944130 |
| 69 | complement activation, alternative pathway (GO:0006957) | 2.76297411 |
| 70 | succinate metabolic process (GO:0006105) | 2.75460408 |
| 71 | muscle system process (GO:0003012) | 2.74627086 |
| 72 | barbed-end actin filament capping (GO:0051016) | 2.74305018 |
| 73 | focal adhesion assembly (GO:0048041) | 2.73021861 |
| 74 | cell-substrate adherens junction assembly (GO:0007045) | 2.73021861 |
| 75 | dicarboxylic acid catabolic process (GO:0043649) | 2.68608593 |
| 76 | alpha-amino acid catabolic process (GO:1901606) | 2.68245587 |
| 77 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.68054516 |
| 78 | striated muscle hypertrophy (GO:0014897) | 2.66534533 |
| 79 | regulation of triglyceride catabolic process (GO:0010896) | 2.65074940 |
| 80 | aspartate family amino acid catabolic process (GO:0009068) | 2.63842424 |
| 81 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.62398325 |
| 82 | glycogen catabolic process (GO:0005980) | 2.62216177 |
| 83 | phospholipid efflux (GO:0033700) | 2.62086845 |
| 84 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.62028283 |
| 85 | neuronal action potential propagation (GO:0019227) | 2.61913722 |
| 86 | cellular potassium ion homeostasis (GO:0030007) | 2.61014261 |
| 87 | myotube cell development (GO:0014904) | 2.60727442 |
| 88 | regulation of cholesterol esterification (GO:0010872) | 2.59968652 |
| 89 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.59522113 |
| 90 | positive regulation of lipid storage (GO:0010884) | 2.59175822 |
| 91 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.58654400 |
| 92 | signal complex assembly (GO:0007172) | 2.57957226 |
| 93 | skin morphogenesis (GO:0043589) | 2.56507614 |
| 94 | muscle hypertrophy (GO:0014896) | 2.56093115 |
| 95 | positive regulation of synapse maturation (GO:0090129) | 2.55683916 |
| 96 | gluconeogenesis (GO:0006094) | 2.55644283 |
| 97 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.54678211 |
| 98 | nitrogen cycle metabolic process (GO:0071941) | 2.54030601 |
| 99 | cellular amino acid catabolic process (GO:0009063) | 2.53323995 |
| 100 | protein targeting to plasma membrane (GO:0072661) | 2.53038016 |
| 101 | valine metabolic process (GO:0006573) | 2.52792137 |
| 102 | indolalkylamine metabolic process (GO:0006586) | 2.52642475 |
| 103 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.52138669 |
| 104 | negative regulation of sterol transport (GO:0032372) | 2.51909445 |
| 105 | negative regulation of cholesterol transport (GO:0032375) | 2.51909445 |
| 106 | sterol catabolic process (GO:0016127) | 2.51892298 |
| 107 | cholesterol catabolic process (GO:0006707) | 2.51892298 |
| 108 | actomyosin structure organization (GO:0031032) | 2.51632728 |
| 109 | locomotory exploration behavior (GO:0035641) | 2.51180560 |
| 110 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.51030054 |
| 111 | protein carboxylation (GO:0018214) | 2.51030054 |
| 112 | negative regulation of lipid transport (GO:0032369) | 2.50809651 |
| 113 | regulation of protein activation cascade (GO:2000257) | 2.50175350 |
| 114 | positive regulation of protein sumoylation (GO:0033235) | 2.49604798 |
| 115 | negative regulation of cell size (GO:0045792) | 2.48886555 |
| 116 | negative regulation of fibrinolysis (GO:0051918) | 2.48778958 |
| 117 | cellular biogenic amine catabolic process (GO:0042402) | 2.48049739 |
| 118 | amine catabolic process (GO:0009310) | 2.48049739 |
| 119 | bile acid metabolic process (GO:0008206) | 2.47962288 |
| 120 | adherens junction assembly (GO:0034333) | 2.47615740 |
| 121 | respiratory system process (GO:0003016) | 2.47265745 |
| 122 | response to mercury ion (GO:0046689) | 2.47056263 |
| 123 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.45586577 |
| 124 | aromatic amino acid family metabolic process (GO:0009072) | 2.45561318 |
| 125 | ketone body metabolic process (GO:1902224) | 2.43158434 |
| 126 | glucan catabolic process (GO:0009251) | 2.42785877 |
| 127 | sodium ion export (GO:0071436) | 2.42190072 |
| 128 | reverse cholesterol transport (GO:0043691) | 2.41775772 |
| 129 | regulation of fibrinolysis (GO:0051917) | 2.41683713 |
| 130 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.41488662 |
| 131 | response to inactivity (GO:0014854) | 2.41299535 |
| 132 | synaptic vesicle maturation (GO:0016188) | 2.40851432 |
| 133 | serine family amino acid catabolic process (GO:0009071) | 2.40552780 |
| 134 | regulation of cholesterol efflux (GO:0010874) | 2.40200146 |
| 135 | cell volume homeostasis (GO:0006884) | 2.39640661 |
| 136 | viral transcription (GO:0019083) | 2.39564991 |
| 137 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.38904886 |
| 138 | muscle hypertrophy in response to stress (GO:0003299) | 2.38904886 |
| 139 | cardiac muscle adaptation (GO:0014887) | 2.38904886 |
| 140 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.38662383 |
| 141 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.38322066 |
| 142 | acetyl-CoA metabolic process (GO:0006084) | 2.37869949 |
| 143 | benzene-containing compound metabolic process (GO:0042537) | 2.37773926 |
| 144 | regulation of synapse structural plasticity (GO:0051823) | 2.36976432 |
| 145 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.36645092 |
| 146 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.35572476 |
| 147 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.35572476 |
| 148 | positive regulation of lipid catabolic process (GO:0050996) | 2.34185729 |
| 149 | cofactor catabolic process (GO:0051187) | 2.33595112 |
| 150 | NAD biosynthetic process (GO:0009435) | 2.33564051 |
| 151 | regulation of translational fidelity (GO:0006450) | 2.33396655 |
| 152 | amino-acid betaine metabolic process (GO:0006577) | 2.32990728 |
| 153 | regulation of complement activation (GO:0030449) | 2.31826728 |
| 154 | muscle cell cellular homeostasis (GO:0046716) | 2.31542474 |
| 155 | indole-containing compound metabolic process (GO:0042430) | 2.31503847 |
| 156 | glucan biosynthetic process (GO:0009250) | 2.31332994 |
| 157 | glycogen biosynthetic process (GO:0005978) | 2.31332994 |
| 158 | plasma membrane repair (GO:0001778) | 2.31283650 |
| 159 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.31088573 |
| 160 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.30869258 |
| 161 | hexose biosynthetic process (GO:0019319) | 2.30489283 |
| 162 | fructose metabolic process (GO:0006000) | 2.30143945 |
| 163 | cerebellar granule cell differentiation (GO:0021707) | 2.30035728 |
| 164 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.28917273 |
| 165 | neuromuscular process controlling balance (GO:0050885) | 2.28403586 |
| 166 | protein-lipid complex remodeling (GO:0034368) | 2.28235874 |
| 167 | macromolecular complex remodeling (GO:0034367) | 2.28235874 |
| 168 | plasma lipoprotein particle remodeling (GO:0034369) | 2.28235874 |
| 169 | monosaccharide biosynthetic process (GO:0046364) | 2.28227354 |
| 170 | UV protection (GO:0009650) | 2.28111658 |
| 171 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.28075115 |
| 172 | negative regulation of lipase activity (GO:0060192) | 2.27478160 |
| 173 | neurotransmitter secretion (GO:0007269) | 2.27396145 |
| 174 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.27292395 |
| 175 | ethanol oxidation (GO:0006069) | 2.27185613 |
| 176 | protein localization to endosome (GO:0036010) | 2.26512254 |
| 177 | monocarboxylic acid catabolic process (GO:0072329) | 2.26300220 |
| 178 | regulation of necrotic cell death (GO:0010939) | 2.25945845 |
| 179 | muscle cell fate commitment (GO:0042693) | 2.25797604 |
| 180 | glutamate secretion (GO:0014047) | 2.25380098 |
| 181 | cell communication by electrical coupling (GO:0010644) | 2.24815872 |
| 182 | homocysteine metabolic process (GO:0050667) | 2.23377442 |
| 183 | carboxylic acid catabolic process (GO:0046395) | 2.22503606 |
| 184 | organic acid catabolic process (GO:0016054) | 2.22503606 |
| 185 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.21430540 |
| 186 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.21001957 |
| 187 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.21001957 |
| 188 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.18181441 |
| 189 | regulation of cell communication by electrical coupling (GO:0010649) | 2.16851306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.06439899 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.01610973 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.35728779 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.91414208 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.89299613 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.82046414 |
| 7 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.69114195 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.55360477 |
| 9 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.53354793 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.35659449 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.29388091 |
| 12 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.23843359 |
| 13 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.21833050 |
| 14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.12629180 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.10932030 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.02374605 |
| 17 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.01146821 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.96112112 |
| 19 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.92942515 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.91111826 |
| 21 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.88047716 |
| 22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.86334294 |
| 23 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.86021175 |
| 24 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.85675356 |
| 25 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.85421558 |
| 26 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.84557391 |
| 27 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.82580864 |
| 28 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.82580864 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.81116918 |
| 30 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.80246638 |
| 31 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.79508328 |
| 32 | P68_20966046_ChIP-Seq_HELA_Human | 1.76598236 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.73830545 |
| 34 | MYC_22102868_ChIP-Seq_BL_Human | 1.69561860 |
| 35 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.69211878 |
| 36 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.68413448 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.67482979 |
| 38 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.67346455 |
| 39 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.66453673 |
| 40 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.66362919 |
| 41 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.64529225 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.64372683 |
| 43 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.60915137 |
| 44 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.59217497 |
| 45 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.55438578 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.55199102 |
| 47 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.55006677 |
| 48 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.53362531 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44322687 |
| 50 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.44000906 |
| 51 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.42746421 |
| 52 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.41265570 |
| 53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39467758 |
| 54 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.39162812 |
| 55 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.38983430 |
| 56 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.38160411 |
| 57 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.37764295 |
| 58 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.33484406 |
| 59 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.32494145 |
| 60 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.31495432 |
| 61 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.30218103 |
| 62 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.29470686 |
| 63 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.28825201 |
| 64 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.27816699 |
| 65 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.27311475 |
| 66 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.26310280 |
| 67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24877476 |
| 68 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.23934619 |
| 69 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.22368463 |
| 70 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.19870578 |
| 71 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.19115269 |
| 72 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.18826334 |
| 73 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.18742185 |
| 74 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.17956414 |
| 75 | MAF_26560356_Chip-Seq_TH2_Human | 1.17191075 |
| 76 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.16674613 |
| 77 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.16382268 |
| 78 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.16122771 |
| 79 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.16053280 |
| 80 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14317427 |
| 81 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.14119971 |
| 82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13959835 |
| 83 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.11974202 |
| 84 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11945314 |
| 85 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11009693 |
| 86 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.10135162 |
| 87 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07915230 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07912992 |
| 89 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07251972 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07173974 |
| 91 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.06974848 |
| 92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06612189 |
| 93 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.06521413 |
| 94 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.05943780 |
| 95 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.05891150 |
| 96 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.04762809 |
| 97 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.04705090 |
| 98 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04368026 |
| 99 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.04343259 |
| 100 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02421446 |
| 101 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02233960 |
| 102 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.01506081 |
| 103 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.00539411 |
| 104 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.00448804 |
| 105 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.00211564 |
| 106 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.99974240 |
| 107 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99235954 |
| 108 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.99136985 |
| 109 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98079919 |
| 110 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97258293 |
| 111 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96999129 |
| 112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96073704 |
| 113 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.92450255 |
| 114 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.91736612 |
| 115 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91141790 |
| 116 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.89627693 |
| 117 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.89620309 |
| 118 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.87299042 |
| 119 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.86899482 |
| 120 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.86440329 |
| 121 | SA1_27219007_Chip-Seq_Bcells_Human | 0.85508244 |
| 122 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.85236297 |
| 123 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.85092496 |
| 124 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.84329297 |
| 125 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.82949137 |
| 126 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.82577348 |
| 127 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.82577348 |
| 128 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.82483378 |
| 129 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.81580133 |
| 130 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.79875048 |
| 131 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78482152 |
| 132 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.77806874 |
| 133 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77111908 |
| 134 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.76425959 |
| 135 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.75784516 |
| 136 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74947257 |
| 137 | MAF_26560356_Chip-Seq_TH1_Human | 0.74489983 |
| 138 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74306344 |
| 139 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.73811716 |
| 140 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.73586211 |
| 141 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.73244819 |
| 142 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.72927748 |
| 143 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.72640660 |
| 144 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.71702029 |
| 145 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.69085202 |
| 146 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.69020734 |
| 147 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.69000137 |
| 148 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.68748859 |
| 149 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.68633136 |
| 150 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.68115745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.88352922 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 3.56904488 |
| 3 | MP0005360_urolithiasis | 3.50537316 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.33767607 |
| 5 | MP0005365_abnormal_bile_salt | 3.08643257 |
| 6 | MP0005083_abnormal_biliary_tract | 2.94031736 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.74469530 |
| 8 | MP0003252_abnormal_bile_duct | 2.71010916 |
| 9 | MP0004510_myositis | 2.61901852 |
| 10 | MP0000750_abnormal_muscle_regeneration | 2.57501078 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.57158336 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.54413259 |
| 13 | MP0004233_abnormal_muscle_weight | 2.52641614 |
| 14 | MP0000759_abnormal_skeletal_muscle | 2.49208336 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.35209571 |
| 16 | MP0003879_abnormal_hair_cell | 2.27389794 |
| 17 | MP0003279_aneurysm | 2.15503321 |
| 18 | MP0003880_abnormal_central_pattern | 2.14700980 |
| 19 | MP0000751_myopathy | 2.10721572 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.07950663 |
| 21 | MP0002254_reproductive_system_inflammat | 1.99691229 |
| 22 | MP0005409_darkened_coat_color | 1.98732216 |
| 23 | MP0003646_muscle_fatigue | 1.96831125 |
| 24 | MP0000685_abnormal_immune_system | 1.91090512 |
| 25 | MP0003635_abnormal_synaptic_transmissio | 1.88338187 |
| 26 | MP0005369_muscle_phenotype | 1.87007318 |
| 27 | MP0002822_catalepsy | 1.83753663 |
| 28 | MP0000343_altered_response_to | 1.81656368 |
| 29 | MP0002269_muscular_atrophy | 1.80123568 |
| 30 | MP0010329_abnormal_lipoprotein_level | 1.78818112 |
| 31 | MP0002332_abnormal_exercise_endurance | 1.75718686 |
| 32 | MP0008438_abnormal_cutaneous_collagen | 1.71998261 |
| 33 | MP0009745_abnormal_behavioral_response | 1.67771539 |
| 34 | MP0002064_seizures | 1.63665580 |
| 35 | MP0000733_abnormal_muscle_development | 1.61978452 |
| 36 | MP0004084_abnormal_cardiac_muscle | 1.58240672 |
| 37 | MP0000003_abnormal_adipose_tissue | 1.56386059 |
| 38 | MP0005387_immune_system_phenotype | 1.52515869 |
| 39 | MP0001790_abnormal_immune_system | 1.52515869 |
| 40 | MP0005332_abnormal_amino_acid | 1.47534022 |
| 41 | MP0005423_abnormal_somatic_nervous | 1.46773806 |
| 42 | MP0002138_abnormal_hepatobiliary_system | 1.44974584 |
| 43 | MP0002909_abnormal_adrenal_gland | 1.44889443 |
| 44 | MP0004130_abnormal_muscle_cell | 1.44080991 |
| 45 | MP0002108_abnormal_muscle_morphology | 1.42766277 |
| 46 | MP0003075_altered_response_to | 1.41922621 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.41286487 |
| 48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.40970565 |
| 49 | MP0009764_decreased_sensitivity_to | 1.39844934 |
| 50 | MP0001348_abnormal_lacrimal_gland | 1.39570927 |
| 51 | MP0001968_abnormal_touch/_nociception | 1.38032238 |
| 52 | MP0000013_abnormal_adipose_tissue | 1.37778988 |
| 53 | MP0002089_abnormal_postnatal_growth/wei | 1.36675129 |
| 54 | MP0003329_amyloid_beta_deposits | 1.35270970 |
| 55 | MP0009379_abnormal_foot_pigmentation | 1.34420372 |
| 56 | MP0009840_abnormal_foam_cell | 1.32334565 |
| 57 | MP0002063_abnormal_learning/memory/cond | 1.31421593 |
| 58 | MP0000749_muscle_degeneration | 1.30835240 |
| 59 | MP0008569_lethality_at_weaning | 1.29646659 |
| 60 | MP0004484_altered_response_of | 1.28262635 |
| 61 | MP0005330_cardiomyopathy | 1.27891110 |
| 62 | MP0002876_abnormal_thyroid_physiology | 1.26896183 |
| 63 | MP0002118_abnormal_lipid_homeostasis | 1.26205004 |
| 64 | MP0009046_muscle_twitch | 1.25279564 |
| 65 | MP0003137_abnormal_impulse_conducting | 1.22780750 |
| 66 | MP0004145_abnormal_muscle_electrophysio | 1.22743111 |
| 67 | MP0010630_abnormal_cardiac_muscle | 1.22507775 |
| 68 | MP0006138_congestive_heart_failure | 1.21306335 |
| 69 | MP0005375_adipose_tissue_phenotype | 1.19103702 |
| 70 | MP0003195_calcinosis | 1.18380830 |
| 71 | MP0004858_abnormal_nervous_system | 1.17328024 |
| 72 | MP0008874_decreased_physiological_sensi | 1.17308145 |
| 73 | MP0005319_abnormal_enzyme/_coenzyme | 1.13152892 |
| 74 | MP0001984_abnormal_olfaction | 1.12849901 |
| 75 | MP0005166_decreased_susceptibility_to | 1.11924215 |
| 76 | MP0000604_amyloidosis | 1.11863971 |
| 77 | MP0002736_abnormal_nociception_after | 1.11704500 |
| 78 | MP0006036_abnormal_mitochondrial_physio | 1.08510830 |
| 79 | MP0005535_abnormal_body_temperature | 1.07495043 |
| 80 | MP0002148_abnormal_hypersensitivity_rea | 1.07279926 |
| 81 | MP0009780_abnormal_chondrocyte_physiolo | 1.05468178 |
| 82 | MP0005257_abnormal_intraocular_pressure | 1.04934986 |
| 83 | MP0009785_altered_susceptibility_to | 1.03933551 |
| 84 | MP0003828_pulmonary_edema | 1.03580002 |
| 85 | MP0000609_abnormal_liver_physiology | 1.03412374 |
| 86 | MP0002272_abnormal_nervous_system | 1.03341509 |
| 87 | MP0004270_analgesia | 1.02206201 |
| 88 | MP0003806_abnormal_nucleotide_metabolis | 1.01584394 |
| 89 | MP0004087_abnormal_muscle_fiber | 1.01402000 |
| 90 | MP0001958_emphysema | 1.01214218 |
| 91 | MP0003172_abnormal_lysosome_physiology | 1.00957146 |
| 92 | MP0001501_abnormal_sleep_pattern | 1.00249996 |
| 93 | MP0005084_abnormal_gallbladder_morpholo | 0.99953586 |
| 94 | MP0001849_ear_inflammation | 0.99426528 |
| 95 | MP0003436_decreased_susceptibility_to | 0.98873728 |
| 96 | MP0008260_abnormal_autophagy | 0.98472346 |
| 97 | MP0001853_heart_inflammation | 0.98211840 |
| 98 | MP0005025_abnormal_response_to | 0.97087436 |
| 99 | MP0002735_abnormal_chemical_nociception | 0.97009473 |
| 100 | MP0010234_abnormal_vibrissa_follicle | 0.96317892 |
| 101 | MP0000920_abnormal_myelination | 0.96255309 |
| 102 | MP0005623_abnormal_meninges_morphology | 0.95608003 |
| 103 | MP0008961_abnormal_basal_metabolism | 0.95445993 |
| 104 | MP0004036_abnormal_muscle_relaxation | 0.95404657 |
| 105 | MP0004215_abnormal_myocardial_fiber | 0.94328970 |
| 106 | MP0005385_cardiovascular_system_phenoty | 0.93360171 |
| 107 | MP0001544_abnormal_cardiovascular_syste | 0.93360171 |
| 108 | MP0000747_muscle_weakness | 0.92950316 |
| 109 | MP0004185_abnormal_adipocyte_glucose | 0.92671305 |
| 110 | MP0003868_abnormal_feces_composition | 0.91650318 |
| 111 | MP0002572_abnormal_emotion/affect_behav | 0.91286228 |
| 112 | MP0004142_abnormal_muscle_tone | 0.89883355 |
| 113 | MP0008469_abnormal_protein_level | 0.89575049 |
| 114 | MP0001800_abnormal_humoral_immune | 0.89070332 |
| 115 | MP0001440_abnormal_grooming_behavior | 0.88964069 |
| 116 | MP0002733_abnormal_thermal_nociception | 0.86579380 |
| 117 | MP0003633_abnormal_nervous_system | 0.85226906 |
| 118 | MP0005671_abnormal_response_to | 0.84383755 |
| 119 | MP0005165_increased_susceptibility_to | 0.84161389 |
| 120 | MP0005000_abnormal_immune_tolerance | 0.83854533 |
| 121 | MP0001502_abnormal_circadian_rhythm | 0.83768027 |
| 122 | MP0005666_abnormal_adipose_tissue | 0.81731807 |
| 123 | MP0002971_abnormal_brown_adipose | 0.81648447 |
| 124 | MP0003638_abnormal_response/metabolism_ | 0.81442883 |
| 125 | MP0001970_abnormal_pain_threshold | 0.81294448 |
| 126 | MP0002877_abnormal_melanocyte_morpholog | 0.81003788 |
| 127 | MP0009333_abnormal_splenocyte_physiolog | 0.80844596 |
| 128 | MP0005620_abnormal_muscle_contractility | 0.80736012 |
| 129 | MP0002078_abnormal_glucose_homeostasis | 0.80124995 |
| 130 | MP0005448_abnormal_energy_balance | 0.79023749 |
| 131 | MP0003303_peritoneal_inflammation | 0.78479140 |
| 132 | MP0003634_abnormal_glial_cell | 0.78460310 |
| 133 | MP0002998_abnormal_bone_remodeling | 0.77356239 |
| 134 | MP0005451_abnormal_body_composition | 0.77216781 |
| 135 | MP0002106_abnormal_muscle_physiology | 0.76609359 |
| 136 | MP0002249_abnormal_larynx_morphology | 0.76087764 |
| 137 | MP0003300_gastrointestinal_ulcer | 0.75955415 |
| 138 | MP0006035_abnormal_mitochondrial_morpho | 0.75792297 |
| 139 | MP0002067_abnormal_sensory_capabilities | 0.74877958 |
| 140 | MP0002972_abnormal_cardiac_muscle | 0.74542559 |
| 141 | MP0001873_stomach_inflammation | 0.73590259 |
| 142 | MP0003705_abnormal_hypodermis_morpholog | 0.73573528 |
| 143 | MP0005503_abnormal_tendon_morphology | 0.73402880 |
| 144 | MP0002166_altered_tumor_susceptibility | 0.73296846 |
| 145 | MP0005670_abnormal_white_adipose | 0.69099599 |
| 146 | MP0009384_cardiac_valve_regurgitation | 0.68933851 |
| 147 | MP0008004_abnormal_stomach_pH | 0.68601185 |
| 148 | MP0001905_abnormal_dopamine_level | 0.67599745 |
| 149 | MP0002127_abnormal_cardiovascular_syste | 0.67471672 |
| 150 | MP0003690_abnormal_glial_cell | 0.67350482 |
| 151 | MP0000678_abnormal_parathyroid_gland | 0.66049492 |
| 152 | MP0003566_abnormal_cell_adhesion | 0.61678352 |
| 153 | MP0003123_paternal_imprinting | 0.59315568 |
| 154 | MP0000681_abnormal_thyroid_gland | 0.57841460 |
| 155 | MP0005595_abnormal_vascular_smooth | 0.56635741 |
| 156 | MP0001727_abnormal_embryo_implantation | 0.56015783 |
| 157 | MP0001661_extended_life_span | 0.55539434 |
| 158 | MP0001915_intracranial_hemorrhage | 0.54256266 |
| 159 | MP0002295_abnormal_pulmonary_circulatio | 0.49082317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 6.43661688 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.29162265 |
| 3 | Nemaline bodies (HP:0003798) | 6.13735705 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 5.85312375 |
| 5 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.52114022 |
| 6 | Neck muscle weakness (HP:0000467) | 4.13753604 |
| 7 | Myopathic facies (HP:0002058) | 4.02791136 |
| 8 | Distal lower limb muscle weakness (HP:0009053) | 3.95321324 |
| 9 | Deep venous thrombosis (HP:0002625) | 3.93549883 |
| 10 | Muscle fiber splitting (HP:0003555) | 3.90323758 |
| 11 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.88451379 |
| 12 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.82123798 |
| 13 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.65407159 |
| 14 | Exercise-induced myalgia (HP:0003738) | 3.64755359 |
| 15 | Increased variability in muscle fiber diameter (HP:0003557) | 3.58252115 |
| 16 | Increased connective tissue (HP:0009025) | 3.51214818 |
| 17 | Axonal loss (HP:0003447) | 3.48134303 |
| 18 | Rhabdomyolysis (HP:0003201) | 3.46239231 |
| 19 | Myokymia (HP:0002411) | 3.38480879 |
| 20 | Ketosis (HP:0001946) | 3.36366248 |
| 21 | Distal arthrogryposis (HP:0005684) | 3.34560157 |
| 22 | Round ear (HP:0100830) | 3.33148947 |
| 23 | Prolonged partial thromboplastin time (HP:0003645) | 3.21700758 |
| 24 | Xanthomatosis (HP:0000991) | 3.18345550 |
| 25 | Focal motor seizures (HP:0011153) | 3.17942794 |
| 26 | Sudden death (HP:0001699) | 3.15179296 |
| 27 | Hyperammonemia (HP:0001987) | 3.11378506 |
| 28 | Ventricular fibrillation (HP:0001663) | 3.05447698 |
| 29 | Intrahepatic cholestasis (HP:0001406) | 2.98013287 |
| 30 | Ketoacidosis (HP:0001993) | 2.96155361 |
| 31 | Ulnar deviation of the wrist (HP:0003049) | 2.95076804 |
| 32 | Neurofibrillary tangles (HP:0002185) | 2.94920308 |
| 33 | Spinal rigidity (HP:0003306) | 2.92403920 |
| 34 | Calf muscle hypertrophy (HP:0008981) | 2.91518038 |
| 35 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.91271426 |
| 36 | Distal lower limb amyotrophy (HP:0008944) | 2.87047748 |
| 37 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.84988688 |
| 38 | Myoglobinuria (HP:0002913) | 2.83160028 |
| 39 | Complement deficiency (HP:0004431) | 2.81988880 |
| 40 | Hypobetalipoproteinemia (HP:0003563) | 2.79051445 |
| 41 | Hyperglycinemia (HP:0002154) | 2.78330092 |
| 42 | Hyperlipoproteinemia (HP:0010980) | 2.77873777 |
| 43 | Bulbar palsy (HP:0001283) | 2.74180904 |
| 44 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.65113183 |
| 45 | Foot dorsiflexor weakness (HP:0009027) | 2.57781341 |
| 46 | Difficulty running (HP:0009046) | 2.57539744 |
| 47 | Protrusio acetabuli (HP:0003179) | 2.56798772 |
| 48 | Abnormality of the Achilles tendon (HP:0005109) | 2.55467459 |
| 49 | Progressive external ophthalmoplegia (HP:0000590) | 2.52393257 |
| 50 | Cerebral inclusion bodies (HP:0100314) | 2.50747272 |
| 51 | Hyperglycinuria (HP:0003108) | 2.49055308 |
| 52 | Status epilepticus (HP:0002133) | 2.48318257 |
| 53 | Scapular winging (HP:0003691) | 2.47121786 |
| 54 | Abnormality of the foot musculature (HP:0001436) | 2.44596255 |
| 55 | Visual hallucinations (HP:0002367) | 2.44329210 |
| 56 | Myotonia (HP:0002486) | 2.43274705 |
| 57 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.41164747 |
| 58 | Calcaneovalgus deformity (HP:0001848) | 2.34633635 |
| 59 | Cerebral edema (HP:0002181) | 2.34181856 |
| 60 | Abnormality of complement system (HP:0005339) | 2.32777416 |
| 61 | Abnormality of glycine metabolism (HP:0010895) | 2.32413792 |
| 62 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.32413792 |
| 63 | Exercise-induced muscle cramps (HP:0003710) | 2.31431425 |
| 64 | Rimmed vacuoles (HP:0003805) | 2.31079738 |
| 65 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.29621027 |
| 66 | Heart block (HP:0012722) | 2.27137760 |
| 67 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.26140688 |
| 68 | Hyperventilation (HP:0002883) | 2.25821071 |
| 69 | Achilles tendon contracture (HP:0001771) | 2.25276677 |
| 70 | Bundle branch block (HP:0011710) | 2.25030286 |
| 71 | Upper motor neuron abnormality (HP:0002127) | 2.24357232 |
| 72 | Cholelithiasis (HP:0001081) | 2.23260960 |
| 73 | Ventricular tachycardia (HP:0004756) | 2.22421451 |
| 74 | Gout (HP:0001997) | 2.21448682 |
| 75 | Joint hemorrhage (HP:0005261) | 2.20549385 |
| 76 | Increased IgM level (HP:0003496) | 2.20375770 |
| 77 | Neonatal onset (HP:0003623) | 2.20193600 |
| 78 | Focal seizures (HP:0007359) | 2.20180818 |
| 79 | Slender build (HP:0001533) | 2.19609868 |
| 80 | Difficulty climbing stairs (HP:0003551) | 2.16089633 |
| 81 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.16070816 |
| 82 | Muscle stiffness (HP:0003552) | 2.15368845 |
| 83 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.14719005 |
| 84 | Subaortic stenosis (HP:0001682) | 2.14719005 |
| 85 | Atrioventricular block (HP:0001678) | 2.12146723 |
| 86 | Agnosia (HP:0010524) | 2.10688973 |
| 87 | Hypoglycemic seizures (HP:0002173) | 2.10242390 |
| 88 | Abnormal atrioventricular conduction (HP:0005150) | 2.09920911 |
| 89 | Colitis (HP:0002583) | 2.09881734 |
| 90 | Febrile seizures (HP:0002373) | 2.09544422 |
| 91 | Hyporeflexia of lower limbs (HP:0002600) | 2.08822806 |
| 92 | Abnormality of the common coagulation pathway (HP:0010990) | 2.07496270 |
| 93 | Acute encephalopathy (HP:0006846) | 2.06159960 |
| 94 | Lower limb amyotrophy (HP:0007210) | 2.05740211 |
| 95 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.04723175 |
| 96 | Dicarboxylic aciduria (HP:0003215) | 2.04723175 |
| 97 | Spontaneous abortion (HP:0005268) | 2.04519191 |
| 98 | Hypolipoproteinemia (HP:0010981) | 2.03617066 |
| 99 | Fat malabsorption (HP:0002630) | 2.02981438 |
| 100 | EMG: neuropathic changes (HP:0003445) | 2.02553331 |
| 101 | Deformed tarsal bones (HP:0008119) | 2.00996773 |
| 102 | Amyloidosis (HP:0011034) | 2.00972454 |
| 103 | Metabolic acidosis (HP:0001942) | 2.00418933 |
| 104 | Generalized muscle weakness (HP:0003324) | 1.99244374 |
| 105 | Abnormal gallbladder morphology (HP:0012437) | 1.97441811 |
| 106 | Myocardial infarction (HP:0001658) | 1.95702296 |
| 107 | Disinhibition (HP:0000734) | 1.94247608 |
| 108 | Panhypogammaglobulinemia (HP:0003139) | 1.94143851 |
| 109 | Abnormality of the calf musculature (HP:0001430) | 1.92343442 |
| 110 | Ventricular arrhythmia (HP:0004308) | 1.91056761 |
| 111 | Asymmetric septal hypertrophy (HP:0001670) | 1.89523162 |
| 112 | Lipoatrophy (HP:0100578) | 1.89331578 |
| 113 | Dilated cardiomyopathy (HP:0001644) | 1.88721611 |
| 114 | Hypoglycemic coma (HP:0001325) | 1.87964212 |
| 115 | Ragged-red muscle fibers (HP:0003200) | 1.87511360 |
| 116 | Hypoalphalipoproteinemia (HP:0003233) | 1.86995982 |
| 117 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.86974945 |
| 118 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.86692867 |
| 119 | Absent phalangeal crease (HP:0006109) | 1.86555807 |
| 120 | Vertebral compression fractures (HP:0002953) | 1.84670460 |
| 121 | Absence seizures (HP:0002121) | 1.84568462 |
| 122 | Syncope (HP:0001279) | 1.84398954 |
| 123 | Generalized amyotrophy (HP:0003700) | 1.83245912 |
| 124 | Hepatic necrosis (HP:0002605) | 1.83033334 |
| 125 | Conjunctival hamartoma (HP:0100780) | 1.82750123 |
| 126 | Systemic lupus erythematosus (HP:0002725) | 1.82227480 |
| 127 | Malignant hyperthermia (HP:0002047) | 1.82022010 |
| 128 | Frequent falls (HP:0002359) | 1.81979010 |
| 129 | Depression (HP:0000716) | 1.81599031 |
| 130 | Anxiety (HP:0000739) | 1.80915157 |
| 131 | Focal dystonia (HP:0004373) | 1.79961054 |
| 132 | Abnormality of the intrinsic pathway (HP:0010989) | 1.79549151 |
| 133 | Rapidly progressive (HP:0003678) | 1.79028409 |
| 134 | Waddling gait (HP:0002515) | 1.78955280 |
| 135 | Obstructive sleep apnea (HP:0002870) | 1.78796081 |
| 136 | Personality changes (HP:0000751) | 1.78695637 |
| 137 | Mask-like facies (HP:0000298) | 1.78311002 |
| 138 | Increased muscle lipid content (HP:0009058) | 1.78044297 |
| 139 | Acute necrotizing encephalopathy (HP:0006965) | 1.75392671 |
| 140 | Hepatocellular necrosis (HP:0001404) | 1.75078088 |
| 141 | Chronic otitis media (HP:0000389) | 1.74454917 |
| 142 | Delayed CNS myelination (HP:0002188) | 1.74357029 |
| 143 | EMG: myopathic abnormalities (HP:0003458) | 1.74237530 |
| 144 | Hypercortisolism (HP:0001578) | 1.73881819 |
| 145 | Torticollis (HP:0000473) | 1.73442225 |
| 146 | Cerebral aneurysm (HP:0004944) | 1.73244761 |
| 147 | Lethargy (HP:0001254) | 1.73226562 |
| 148 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.72853061 |
| 149 | Areflexia of lower limbs (HP:0002522) | 1.72675340 |
| 150 | Tinnitus (HP:0000360) | 1.71759332 |
| 151 | Mitral stenosis (HP:0001718) | 1.71415003 |
| 152 | Gastrointestinal infarctions (HP:0005244) | 1.70588645 |
| 153 | Progressive muscle weakness (HP:0003323) | 1.70566988 |
| 154 | Steatorrhea (HP:0002570) | 1.69970230 |
| 155 | Abnormality of purine metabolism (HP:0004352) | 1.69568169 |
| 156 | Epidermoid cyst (HP:0200040) | 1.68909805 |
| 157 | Craniofacial dystonia (HP:0012179) | 1.68873227 |
| 158 | Supranuclear gaze palsy (HP:0000605) | 1.68671172 |
| 159 | Recurrent cutaneous fungal infections (HP:0011370) | 1.68515471 |
| 160 | Ulnar bowing (HP:0003031) | 1.67761627 |
| 161 | Premature rupture of membranes (HP:0001788) | 1.66197603 |
| 162 | Thoracic kyphosis (HP:0002942) | 1.65098455 |
| 163 | Abnormality of the calcaneus (HP:0008364) | 1.64303928 |
| 164 | Gowers sign (HP:0003391) | 1.61944796 |
| 165 | Limb-girdle muscle atrophy (HP:0003797) | 1.61751360 |
| 166 | Weak cry (HP:0001612) | 1.59327548 |
| 167 | Reticulocytosis (HP:0001923) | 1.57301941 |
| 168 | Oligomenorrhea (HP:0000876) | 1.54912680 |
| 169 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.54011222 |
| 170 | Abnormality of glycolipid metabolism (HP:0010969) | 1.54011222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.10425554 |
| 2 | BCKDK | 2.71165968 |
| 3 | RIPK4 | 2.65785082 |
| 4 | NTRK3 | 2.52513287 |
| 5 | EEF2K | 2.27918678 |
| 6 | DAPK2 | 2.10045713 |
| 7 | MAP3K12 | 2.00134550 |
| 8 | ERN1 | 1.98534364 |
| 9 | MAP4K1 | 1.97211542 |
| 10 | EPHA4 | 1.90189050 |
| 11 | PKN2 | 1.87006680 |
| 12 | MAP2K4 | 1.84026948 |
| 13 | NME2 | 1.73125698 |
| 14 | MAP3K7 | 1.66700804 |
| 15 | PHKG1 | 1.66245323 |
| 16 | PHKG2 | 1.66245323 |
| 17 | FGFR4 | 1.58569447 |
| 18 | ICK | 1.56473256 |
| 19 | CAMKK1 | 1.56445986 |
| 20 | KSR2 | 1.50591731 |
| 21 | TBK1 | 1.47350520 |
| 22 | MAP3K4 | 1.44282884 |
| 23 | MAP3K13 | 1.42556059 |
| 24 | RIPK1 | 1.41695815 |
| 25 | SIK2 | 1.40103468 |
| 26 | LMTK2 | 1.39281437 |
| 27 | MAP3K14 | 1.37121383 |
| 28 | MAPKAPK3 | 1.33977431 |
| 29 | PINK1 | 1.31390682 |
| 30 | MAP3K11 | 1.30412929 |
| 31 | MAP3K9 | 1.30394230 |
| 32 | MINK1 | 1.28505620 |
| 33 | SIK1 | 1.27466756 |
| 34 | TNK2 | 1.24532110 |
| 35 | TTN | 1.23010699 |
| 36 | DMPK | 1.22419127 |
| 37 | PRKCH | 1.20004683 |
| 38 | SYK | 1.19737174 |
| 39 | MARK2 | 1.15878160 |
| 40 | LRRK2 | 1.14976409 |
| 41 | ARAF | 1.14040162 |
| 42 | PRKD2 | 1.13147081 |
| 43 | ABL2 | 1.13105547 |
| 44 | JAK1 | 1.12493131 |
| 45 | GRK5 | 1.09050137 |
| 46 | OBSCN | 1.08444936 |
| 47 | MAP3K3 | 1.07196513 |
| 48 | MOS | 1.06500392 |
| 49 | SIK3 | 1.06114949 |
| 50 | STK38 | 1.03500842 |
| 51 | TESK1 | 1.02802668 |
| 52 | IRAK3 | 1.02743411 |
| 53 | LATS2 | 1.01431432 |
| 54 | TAOK2 | 0.99492147 |
| 55 | MAP2K7 | 0.98440756 |
| 56 | FLT3 | 0.95210947 |
| 57 | MAP3K1 | 0.94498366 |
| 58 | TYK2 | 0.93889961 |
| 59 | BMPR2 | 0.92441086 |
| 60 | RAF1 | 0.92007104 |
| 61 | GRK6 | 0.91776097 |
| 62 | ILK | 0.90714977 |
| 63 | KIT | 0.85476360 |
| 64 | PRKCQ | 0.84058962 |
| 65 | MAP3K2 | 0.84014267 |
| 66 | SMG1 | 0.83710819 |
| 67 | PIM2 | 0.83494306 |
| 68 | DAPK3 | 0.83320813 |
| 69 | JAK3 | 0.83247261 |
| 70 | CDK19 | 0.82798953 |
| 71 | DAPK1 | 0.82449862 |
| 72 | RET | 0.82433726 |
| 73 | FES | 0.82349194 |
| 74 | RPS6KA2 | 0.82108882 |
| 75 | IKBKE | 0.82091285 |
| 76 | JAK2 | 0.81692944 |
| 77 | SGK3 | 0.80120101 |
| 78 | MAPK12 | 0.79655578 |
| 79 | MUSK | 0.79491997 |
| 80 | PIK3CG | 0.77687945 |
| 81 | PDK1 | 0.77472361 |
| 82 | TAOK1 | 0.74520752 |
| 83 | IKBKB | 0.74517220 |
| 84 | PAK6 | 0.72234059 |
| 85 | SGK2 | 0.71755691 |
| 86 | TLK1 | 0.70338622 |
| 87 | LIMK1 | 0.69719734 |
| 88 | PRKD3 | 0.68567676 |
| 89 | CAMK1 | 0.68353256 |
| 90 | BRAF | 0.66793136 |
| 91 | MYLK | 0.66552735 |
| 92 | PDPK1 | 0.65914384 |
| 93 | MAP2K6 | 0.64726587 |
| 94 | MAPK11 | 0.63843555 |
| 95 | MARK1 | 0.63481339 |
| 96 | NTRK2 | 0.63225802 |
| 97 | PRPF4B | 0.60889599 |
| 98 | NTRK1 | 0.60624633 |
| 99 | KSR1 | 0.60217149 |
| 100 | CAMKK2 | 0.60046890 |
| 101 | CDK5 | 0.59312540 |
| 102 | DDR2 | 0.58348882 |
| 103 | BMX | 0.58101420 |
| 104 | TGFBR2 | 0.57678862 |
| 105 | SCYL2 | 0.56754280 |
| 106 | MTOR | 0.56588294 |
| 107 | MAP3K8 | 0.55471711 |
| 108 | PDGFRA | 0.55410688 |
| 109 | EPHB1 | 0.55247605 |
| 110 | NME1 | 0.55139296 |
| 111 | MAP2K1 | 0.54871751 |
| 112 | CDC42BPA | 0.54338645 |
| 113 | BTK | 0.54278907 |
| 114 | MAP2K3 | 0.54049489 |
| 115 | CSF1R | 0.53744878 |
| 116 | CAMK2G | 0.52914307 |
| 117 | RPS6KC1 | 0.52385863 |
| 118 | RPS6KL1 | 0.52385863 |
| 119 | TESK2 | 0.51852266 |
| 120 | MAPK4 | 0.51272929 |
| 121 | TAOK3 | 0.50637595 |
| 122 | MAP3K10 | 0.50368403 |
| 123 | CAMK4 | 0.49992195 |
| 124 | PRKCG | 0.49736926 |
| 125 | AKT2 | 0.49697509 |
| 126 | KDR | 0.49476624 |
| 127 | PTK6 | 0.48228048 |
| 128 | SGK223 | 0.47714225 |
| 129 | SGK494 | 0.47714225 |
| 130 | DYRK1B | 0.47523667 |
| 131 | GRK7 | 0.47470618 |
| 132 | CDK11A | 0.45864517 |
| 133 | PRKD1 | 0.45570565 |
| 134 | HCK | 0.44808860 |
| 135 | RPS6KB2 | 0.44554643 |
| 136 | CAMK2B | 0.44425368 |
| 137 | IRAK1 | 0.44326499 |
| 138 | TIE1 | 0.43162284 |
| 139 | TRPM7 | 0.42518279 |
| 140 | CDK15 | 0.42065126 |
| 141 | PRKAA1 | 0.41763148 |
| 142 | PRKG2 | 0.40983502 |
| 143 | NEK9 | 0.40608054 |
| 144 | MAPK7 | 0.39406352 |
| 145 | PAK2 | 0.37451105 |
| 146 | CDK14 | 0.36534511 |
| 147 | ROCK1 | 0.36335237 |
| 148 | UHMK1 | 0.36007375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.45531885 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.55318448 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.27458548 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.59181546 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.02682877 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.87257423 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.83135484 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 1.81826862 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.73734729 |
| 10 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.64924856 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.62075589 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.61737051 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.55155410 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.50110506 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.47561188 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.42273989 |
| 17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.42020665 |
| 18 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.42015373 |
| 19 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.41769298 |
| 20 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.39861053 |
| 21 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.39341393 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.35718153 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.32140132 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.31259974 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.30417643 |
| 26 | Olfactory transduction_Homo sapiens_hsa04740 | 1.30381624 |
| 27 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.23603958 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.17758324 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15311984 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.13592715 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11528749 |
| 32 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.11287313 |
| 33 | Nicotine addiction_Homo sapiens_hsa05033 | 1.10759414 |
| 34 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.09030850 |
| 35 | GABAergic synapse_Homo sapiens_hsa04727 | 1.08040088 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.08016404 |
| 37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.07129301 |
| 38 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.06192792 |
| 39 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.06170824 |
| 40 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.04409042 |
| 41 | Parkinsons disease_Homo sapiens_hsa05012 | 1.02922199 |
| 42 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.01731897 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.01461146 |
| 44 | Circadian entrainment_Homo sapiens_hsa04713 | 1.01305336 |
| 45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.97120460 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96334433 |
| 47 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.94356069 |
| 48 | Alzheimers disease_Homo sapiens_hsa05010 | 0.92474624 |
| 49 | Focal adhesion_Homo sapiens_hsa04510 | 0.92333588 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89708409 |
| 51 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.89033187 |
| 52 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.88577393 |
| 53 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.88132749 |
| 54 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.87641533 |
| 55 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86658710 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.86488980 |
| 57 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.86268975 |
| 58 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.85908757 |
| 59 | Galactose metabolism_Homo sapiens_hsa00052 | 0.85827012 |
| 60 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.83706057 |
| 61 | Morphine addiction_Homo sapiens_hsa05032 | 0.83187099 |
| 62 | Long-term potentiation_Homo sapiens_hsa04720 | 0.82847360 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.81715615 |
| 64 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.81615037 |
| 65 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.81490473 |
| 66 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.81083826 |
| 67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.81044833 |
| 68 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81034205 |
| 69 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.80831164 |
| 70 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.80274101 |
| 71 | Melanogenesis_Homo sapiens_hsa04916 | 0.80241255 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.79543767 |
| 73 | Salivary secretion_Homo sapiens_hsa04970 | 0.79078956 |
| 74 | Glioma_Homo sapiens_hsa05214 | 0.78750971 |
| 75 | Ribosome_Homo sapiens_hsa03010 | 0.77748765 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76981380 |
| 77 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.75773289 |
| 78 | Carbon metabolism_Homo sapiens_hsa01200 | 0.75093701 |
| 79 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.74235032 |
| 80 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73208812 |
| 81 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.72740190 |
| 82 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.72086472 |
| 83 | Bladder cancer_Homo sapiens_hsa05219 | 0.71826839 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71133013 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70785812 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.69421571 |
| 87 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.68973241 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68841373 |
| 89 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68740437 |
| 90 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.68551112 |
| 91 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.68038680 |
| 92 | Insulin secretion_Homo sapiens_hsa04911 | 0.66570446 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.66245263 |
| 94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66211801 |
| 95 | Lysosome_Homo sapiens_hsa04142 | 0.65631674 |
| 96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65575257 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.64952644 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.64243041 |
| 99 | Gap junction_Homo sapiens_hsa04540 | 0.63985167 |
| 100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63279803 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.62768128 |
| 102 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.62371933 |
| 103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61644741 |
| 104 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.61514928 |
| 105 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.61494486 |
| 106 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61135841 |
| 107 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60990806 |
| 108 | Histidine metabolism_Homo sapiens_hsa00340 | 0.59172456 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58824394 |
| 110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58718122 |
| 111 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57927138 |
| 112 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57541151 |
| 113 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56800044 |
| 114 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.56546538 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55583680 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54508769 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.54201382 |
| 118 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52550286 |
| 119 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52544761 |
| 120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52265908 |
| 121 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.51526142 |
| 122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51444611 |
| 123 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51436689 |
| 124 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51379350 |
| 125 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.51049983 |
| 126 | Renin secretion_Homo sapiens_hsa04924 | 0.50592129 |
| 127 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.50463088 |
| 128 | Taste transduction_Homo sapiens_hsa04742 | 0.50162848 |
| 129 | Allograft rejection_Homo sapiens_hsa05330 | 0.48305774 |
| 130 | Pertussis_Homo sapiens_hsa05133 | 0.48217041 |
| 131 | Prion diseases_Homo sapiens_hsa05020 | 0.47190084 |
| 132 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.45615442 |
| 133 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45561145 |
| 134 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.44609751 |
| 135 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44354418 |
| 136 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.43841690 |
| 137 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43512913 |
| 138 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43482652 |
| 139 | Leishmaniasis_Homo sapiens_hsa05140 | 0.42827203 |
| 140 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42209477 |
| 141 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.41721473 |
| 142 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41688098 |
| 143 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41424539 |
| 144 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41284022 |
| 145 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.41195606 |
| 146 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41017108 |
| 147 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.40478209 |
| 148 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.40162075 |
| 149 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38676154 |
| 150 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37007005 |
| 151 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36928306 |
| 152 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36353205 |
| 153 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36327612 |
| 154 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.36134404 |
| 155 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35267126 |

